| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/27/2014 | WO2014031881A2 Activity-dependent gene pairs as therapeutic targets and methods and devices to identify the same |
| 02/27/2014 | WO2014031859A2 Compositions and methods relating to blood-based biomarkers of breast cancer |
| 02/27/2014 | WO2014031850A1 A novel polymavirus associated with diarrhea in children |
| 02/27/2014 | WO2014031783A1 Detection of an amplification reaction product using ph-sensitive dyes |
| 02/27/2014 | WO2014031770A2 Multiple-virus-resistant melon |
| 02/27/2014 | WO2014031681A1 Inhibiting gram positive bacteria |
| 02/27/2014 | WO2014031631A1 Compositions and methods for using transfer rna fragments as biomarkers for cancer |
| 02/27/2014 | WO2014031610A1 Methods for treating or preventing asthma by administering an il-4r antagonist |
| 02/27/2014 | WO2014031609A1 Expression of protein-coding and noncoding genes as prognostic classifiers in early stage lung cancer |
| 02/27/2014 | WO2014031498A1 Cell-permeable probes for identification and imaging of sialidases |
| 02/27/2014 | WO2014031253A1 Device and method for performing blood thromboelastographic assays by magnetic sensing |
| 02/27/2014 | WO2014031211A2 Methods for detecting hepatitis b virus surface gene non-sense mutations |
| 02/27/2014 | WO2014031163A1 Methods, compositions, systems, apparatuses and kits for nucleic acid paired end sequencing |
| 02/27/2014 | WO2014031079A1 Method and/or probe for determining glaucoma susceptibility |
| 02/27/2014 | WO2014031018A1 Method for efficient isolation of microbial dna from blood |
| 02/27/2014 | WO2014030778A1 Silver nanocluster probe and target polynucleotide detection method using same, and silver nanocluster probe design method |
| 02/27/2014 | WO2014030774A1 Medium for yeasts |
| 02/27/2014 | WO2014030729A1 Method for examining microorganism and device for same |
| 02/27/2014 | WO2014030675A1 Method for determining auxotrophy in industrial animal |
| 02/27/2014 | WO2014030674A1 Culture medium information registration system, colony detection device, program, and health management system |
| 02/27/2014 | WO2014030673A1 Culture-medium information registration system, health management system, and program |
| 02/27/2014 | WO2014030641A1 Support for cell culture and method for producing protein or peptide using cultured cells |
| 02/27/2014 | WO2014030602A1 Agent for treating cancer |
| 02/27/2014 | WO2014030066A2 Methods for identifying nucleic acid sequences |
| 02/27/2014 | WO2014029851A1 Diagnosis of hpv-induced cancer |
| 02/27/2014 | WO2014029791A1 Method for isolating nucleic acids from a formaldehyde releaser stabilized sample |
| 02/27/2014 | WO2014029376A1 Method for producing vectors containing a gene that codes for an enzyme having reduced or switched-off feedback inhibition, and use thereof for producing amino acids and nucleotides |
| 02/27/2014 | WO2014029093A1 Method and system for determining whether individual is in abnormal state |
| 02/27/2014 | WO2014028974A1 Diagnostic markers for spondyloarthropathies and uses thereof |
| 02/27/2014 | WO2014014988A3 Cooperative primers, probes, and applications thereof |
| 02/27/2014 | WO2014011465A3 Aptamer-targeted antigen delivery |
| 02/27/2014 | WO2014009055A9 Method and kit for predicting or monitoring the response of a cancer patient to chemotherapy, based on measuring the expression level of tmem45a gene. |
| 02/27/2014 | WO2014007620A3 Oligonucleotide for the treatment of muscular dystrophy patients |
| 02/27/2014 | WO2014006061A3 Restriction endonucleases and their use |
| 02/27/2014 | WO2014004609A3 Rapid assays for t-cell activation by rna measurements using flow cytometry |
| 02/27/2014 | WO2013190441A3 Mutational analysis of plasma dna for cancer detection |
| 02/27/2014 | WO2013188978A8 Apparatus and method for quantification of replicative lifespan and observation of senescence |
| 02/27/2014 | WO2013188600A9 Copy number aberration driven endocrine response gene signature |
| 02/27/2014 | WO2013187958A8 Methods and compositions for detection of legionella |
| 02/27/2014 | WO2013175318A3 Microbead agglutination based assays |
| 02/27/2014 | WO2013175313A3 Methods and systems for the detection of ricin and other ribosome inactivating proteins |
| 02/27/2014 | WO2013172779A3 Method for indicating the presence or non-presence of prostate cancer |
| 02/27/2014 | WO2013153458A3 Method for the prognosis and treatment of cancer metastasis |
| 02/27/2014 | WO2013103899A3 Phosphorylation of histones and uses thereof |
| 02/27/2014 | WO2012149188A3 Compositions and methods for detecting and identifying nucleic acid sequences in biological samples |
| 02/27/2014 | WO2012138973A3 COMPOSITION AND METHODS RELATED TO MODIFICATION OF 5-METHYLCYTOSINE (5mC) |
| 02/27/2014 | WO2012122219A3 Predictive marker of dnmt1 inhibitor therapeutic efficacy and methods of using the marker |
| 02/27/2014 | US20140059722 Biosensors |
| 02/27/2014 | US20140059712 Multiple-virus-resistant melon |
| 02/27/2014 | US20140058000 Diagnostic markers for determining the predisposition to the development of cervical cancer and oligonucleotides used for the determination |
| 02/27/2014 | US20140057986 Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type |
| 02/27/2014 | US20140057971 LaFORA'S DISEASE GENE |
| 02/27/2014 | US20140057967 Method of screening for chaperonin modulator |
| 02/27/2014 | US20140057966 Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors |
| 02/27/2014 | US20140057962 Compositions and Methods for the Treatment of Cancer |
| 02/27/2014 | US20140057903 Methods for characterizing and treating cognitive impairment in aging and disease |
| 02/27/2014 | US20140057888 Compounds and their use |
| 02/27/2014 | US20140057865 Analysis of nodes in cellular pathways |
| 02/27/2014 | US20140057863 Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation |
| 02/27/2014 | US20140057806 Probe, probe set, probe carrier, and testing method |
| 02/27/2014 | US20140057802 Method and kit for determining in vitro the probability for an individual to suffer from colorectal cancer |
| 02/27/2014 | US20140057800 Single nucleotide polymorphism associated with risk of insulin resistance development |
| 02/27/2014 | US20140057799 System and Methods for Massively Parallel Analysis of Nucleic Acids in Single Cells |
| 02/27/2014 | US20140057798 Prediction of drug sensitivity of lung tumors based on molecular genetic signatures |
| 02/27/2014 | US20140057797 Methods for Detecting an increased risk for coronary heart disease |
| 02/27/2014 | US20140057796 Method for the Diagnosis, Prognosis and Treatment of Breast Cancer Metastasis |
| 02/27/2014 | US20140057795 Methods and Compositions for Correlating Genetic Markers with Prostate Cancer Risk |
| 02/27/2014 | US20140057794 Lung cancer signature |
| 02/27/2014 | US20140057347 Method and apparatus for preparing cytological specimens |
| 02/27/2014 | US20140057341 Live bioload detection using microparticles |
| 02/27/2014 | US20140057314 Methods and compositions for detecting microbial production of water-immiscible compounds |
| 02/27/2014 | US20140057285 Compositions and methods targeting force generation in kinesin |
| 02/27/2014 | US20140057284 Photoluminescent molecular complex and method for determining of the concentration of said molecular complex |
| 02/27/2014 | US20140057283 Impedance based devices and methods for use in assays |
| 02/27/2014 | US20140057279 Devices and methods for biological sample-to-answer and analysis |
| 02/27/2014 | US20140057276 Dna tagged microparticles |
| 02/27/2014 | US20140057275 Detecting multinucleotide repeats |
| 02/27/2014 | US20140057274 Methods for sequencing polynucleotides |
| 02/27/2014 | US20140057272 Method for immune cell-assisted bacterial culturing |
| 02/27/2014 | US20140057270 Compositions and methods for detecting mutations in jak2 nucleic acid |
| 02/27/2014 | US20140057269 Materials and Methods for Detection of Nucleic Acids |
| 02/27/2014 | US20140057266 Methods and materials for detecting genetic or epigenetic elements |
| 02/27/2014 | US20140057265 Composition and method for determination of ck19 expression |
| 02/27/2014 | US20140057264 Detection of target nucleic acid sequence by pto cleavage and extension-dependent cleavage |
| 02/27/2014 | US20140057263 Modified hybridization probes |
| 02/27/2014 | US20140057262 Methods and materials for using the contents of phagocytes to detect neoplasms |
| 02/27/2014 | US20140057260 MATERIALS AND METHOD FOR ASSAYING FOR METHYLATION OF CpG ISLANDS ASSOCIATED WITH GENES IN THE EVALUATION OF CANCER |
| 02/27/2014 | US20140057259 Methods for analysis of nucleic acid molecules during amplification reactions |
| 02/27/2014 | US20140057258 Method of diagnosing mild osteoarthritis |
| 02/27/2014 | US20140057257 In vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method |
| 02/27/2014 | US20140057256 Hairpin-type probe for detecting target material and method for detecting target material using the same |
| 02/27/2014 | US20140057255 Systems and Methods for Collecting and Transmitting Assay Results |
| 02/27/2014 | US20140057254 Methods and reagents for reducing non-specific amplification |
| 02/27/2014 | US20140057253 Method to predict the pattern of locomotion in horses |
| 02/27/2014 | US20140057252 Binary DNA Probe for Fluorescent Analysis of Nucleic Acids |
| 02/27/2014 | US20140057251 Cannabis Genomes and Uses Thereof |
| 02/27/2014 | US20140057249 Jak/stat inhibitors and mapk/erk inhibitors for rsv infection |
| 02/27/2014 | US20140057248 Fluorescence energy transfer by competitive hybridization |
| 02/27/2014 | US20140056998 System and method for diagnosis and treatment of neuropsychiatric disorders |
| 02/27/2014 | US20140056911 Breast Endothelial Cell Expression Patterns |